Pemphigus Vulgaris Clinical Trials

46 clinical trials for Pemphigus Vulgaris across international registries, including 6 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• CD19 CAR-T Therapy for Refractory Pemphigus Vulgaris — RECRUITING · NA
• A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV) — RECRUITING · PHASE1
• Autoimmune Blistering Diseases Study — RECRUITING
• Periodontal Status and Disease Severity in Pemphigus Vulgaris Patients — RECRUITING
• Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Diseases. — RECRUITING · PHASE1
• "A RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, ACTIVE-COMPARATOR, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF RITUXIMAB VERSUS MMF IN PATIENTS WITH PEMPHIGUS VULGARIS." — RECRUITING
• COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders — TERMINATED · PHASE2
• Effect of Topical Insulin on Healing Rate of Pemphigus Lesions — COMPLETED · PHASE2
• Evaluating Legit.Health Plus Support for Improving Diagnosis of Generalized Pustular Psoriasis and Other Skin Conditions Among Primary Care Physicians and Dermatologists — COMPLETED
• Testing of a new test system for diagnosis and therapy planning of severe blistering autoimmune diseases of the skin — OTHER
• Low-level Laser Therapy on Oral Pemphigus Vulgaris Patients. — NOT_YET_RECRUITING · NA
• A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod PH20 SC in Adults With Pemphigus (Vulgaris or Foliaceus) — TERMINATED · PHASE3
• Trichoscopy as a Monitoring Tool for Activity and Remission in Pemphigus Vulgaris: A Clinical Study Supported by Immunological Evaluation. — NOT_YET_RECRUITING
• Comparing DCP and DAP for Pemphigus Vulgaris — COMPLETED · PHASE4
• A Randomized Study on Pemphigus Treatment With Humanized CD38 Antibody CM313. — NOT_YET_RECRUITING · PHASE1
• Efficacy and Safety Evaluation of Anti-CD20 Monoclonal Antibody Combined with Azathioprine and Corticosteroids in the Treatment of Pemphigus Vulgaris — COMPLETED
• A Study to Assess the Efficacy and Safety of a Subcutaneous Formulation of Efgartigimod PH20 SC in Adults With Pemphigus (Vulgaris or Foliaceus) — COMPLETED · PHASE3
• Trace element analyses in inflammatory and autoimmune skin diseases — NOT_YET_RECRUITING
• Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives — OTHER
• Polyclonal Regulatory T Cells (PolyTregs) for Pemphigus — TERMINATED · PHASE1
• Efficacy and safety of adjuvant immunoadsorption in pemphigus — OTHER
• Dexamethasone Solution and Dexamethasone in Mucolox™ — COMPLETED · PHASE2
• Identifying Factors Influencing In-Hospital Relapse in Pemphigus Patients — COMPLETED
• A multi-centre, open-label, phase 1 study, Part A single ascending dose and Part B multiple dose, to evaluate the safety, tolerability and pharmacokinetics, and to explore early signs of effectiveness of induction of antigen-specific immune tolerance with TPM203 in pemphigus vulgaris patients — OTHER
• Role of Tzanck Smear in Determining Pemphigus Vulgaris Disease Activity — OTHER
• A Study of PRN1008 in Adult Patients With Pemphigus Vulgaris — COMPLETED · PHASE2
• Safety, Efficacy and Clinical Outcome of the Immunosorba® and GLOBAFFIN® System — OTHER
• Ozonated Olive Oil in Treatment of Pemphigus Vulgaris and Bullous Pemphigoid — OTHER · PHASE3
• Comparative Analysis of the Th17 Cellular Response in Active and Inactive Pemphigus Vulgaris Patients — OTHER
• A Study to Evaluate Efficacy and Safety of Abatacept in Participants of Pemphigus Vulgaris (PV) — OTHER · PHASE4
• Study of Efficacy and Safety of VAY736 in Patients With Pemphigus Vulgaris — TERMINATED · PHASE2
• Efficacy of Interleukin-2 Gargle in the Treatment of Oral Mucosa Lesion in Pemphigus Vulgaris — OTHER · PHASE2
• Phenotypic and Functional Characterisation of Human B-cell Response in Pemphigus — OTHER · NA
• A Study to Evaluate the Safety, PD, PK and Efficacy of ARGX-113 in Patients With Pemphigus — COMPLETED · PHASE2
• A Study to Evaluate the Efficacy and Safety of Rituximab Versus Mycophenolate Mofetil (MMF) in Participants With Pemphigus Vulgaris (PV) — COMPLETED · PHASE3
• A Safety and Dose-Finding Study of SYNT001 in Subjects With Pemphigus (Vulgaris or Foliaceus) — TERMINATED · PHASE1
• A Study of the Safety and Tolerability of INCB050465 in Pemphigus Vulgaris — WITHDRAWN · PHASE2
• Efficacy and Safety of Ofatumumab in Treatment of Pemphigus Vulgaris — TERMINATED · PHASE3
• Serum IL-21 Levels in Patients With Pemphigus Vulgaris — OTHER
• Randomized Trial of IVIg With or Without Cyclophosphamide in Pemphigus — TERMINATED · PHASE2
• Study of Etanercept (Enbrel) in the Treatment of Pemphigus Vulgaris — COMPLETED · PHASE2
• A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Patients With Active Pemphigus Vulgaris (PV) — COMPLETED · PHASE3
• Azathioprine Versus Placebo in Pemphigus Vulgaris Treated With Prednisolone — COMPLETED · PHASE2
• Use of KC706 for the Treatment of Pemphigus Vulgaris — COMPLETED · PHASE2
• Efficacy of Dapsone as a Steroid Sparing Agent in Pemphigus Vulgaris — TERMINATED · PHASE2
• Safety Study of PI-0824 to Treat Pemphigus Vulgaris — COMPLETED · PHASE1

Refine this search